Record #3225

Consensus Guidelines for CSF and Blood Biobanking for CNS Biomarker Studies

Publisher
Original paper date
Jul 18, 2011
Institution
Department of Clinical Chemistry, Neurological Laboratory and Biobank, VU University Medical Center, FdG, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands · Clinical Neuroimmunology Unit, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, 20132 Milan, Italy · Neurology, Erasmus MC, Rotterdam, The Netherlands · Clinical Developement Department, Isis Pharmaceuticals, Carlsbad, California 92024, USA · OncoProteomics Laboratory, Department of Medical Oncology, VU University Medical Center, 1007 MB Amsterdam, The Netherlands · Department of Neurology, Leeds Teaching Hospitals NHS Trust, Leeds LS1 3EX, UK · Department of Neurology and Center of Clinical Neuroscience, 1st Faculty of Medicine and General University Hospital, Charles University, 128 21 Prague, Czech Republic · Department of Neurology, VU University Medical Center, 1007 MB Amsterdam, The Netherlands · Neurology and Clinical Neuroimmunology, University Hospital, University of Basel, Basel 4031, Switzerland · F. Hoffmann- La Roche Pharma, Basel, Switzerland · Department of Neuroimmunology, UCL Institute of Neurology, Queen Square, wc1n 3bg London, UK · University of Ulm, Ulm 89081, Germany · Department of Neurology, University of Szeged, Szeged, Hungary · Department of Neurology, Medical University of Lublin, Lublin, Poland · Department of Experimental Pharmacology, Medical Research Center, Warsaw, MA 02451, Poland · Accelerated Cure Project for Multiple Sclerosis, Waltham, MA, USA · Neurology Department UCL, Université Catholique de Louvain, Brussels CA94117, Belgium · Clinical Development, Lycalis sprl, 1180 Brussels, Belgium · Clinical Development, UCB Pharma S.A., 6020 Braine l'Alleud, Belgium · Department of Clinical Neurology, Innsbruck Medical University, Innsbruck E1 2AT, Austria · Queen Mary University of London, Neuroscience & Trauma Centre, Blizard Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, London, UK · Deptartment of Neurology, Klinikum rechts der Isar, Technische Universität, Munich 81245, Germany · Departments of Neurology & Ophthalmology, University of Colorado Denver, Aurora, USA · Proteomics Unit (PROBE), Department of Biomedicine, University of Bergen, Bergen 5020, Norway · Division Neurology, Department Clin Neuroscience, Karolinska University Hospital, Stockholm, Sweden · Neurology, Centre d'Esclerosi Múltiple de Catalunya, CEM-Cat, Unitat de Neuroimmunologia Clínica, Hospital Universitari Vall d'Hebron, Barcelona, Spain · Laboratory of Neuroimmunology, IRCCS, “C. Mondino Neurological Institute”, Pavia, Italy · Neurology, Glostrup Hospital, University of Copenhagen, Glostrup 2600, Denmark · Department of Neurology, University of Wisconsin, Madison 53705, WI, USA
Open access
No
Article type
Citation lifecycle

How this paper is being cited

Pre-retraction
30
Same day
0
Post-retraction
26
% post-retraction
46.4%
~6.0 citations/yr before retraction · ~2.6 citations/yr after
citing papers

Who is still citing this work

Loading…